Literature DB >> 9311805

Retrovirus-induced target cell activation in the early phases of infection: the mouse mammary tumor virus model.

C Ardavin1, F Luthi, M Andersson, L Scarpellino, P Martin, H Diggelmann, H Acha-Orbea.   

Abstract

Mouse mammary tumor virus (MMTV) infects B lymphocytes and expresses a superantigen on the cell surface after integration of its reverse-transcribed genome. Superantigen-dependent B- and T-cell activation becomes detectable 2 to 3 days after infection. We show here that before this event, B cells undergo a polyclonal activation which does not involve massive proliferation. This first phase of B-cell activation is T cell independent. Moreover, during the first phase of activation, when only a small fraction of B cells is infected by MMTV(SW), viral DNA is detected only in activated B cells. Such a B-cell activation is also seen after injection of murine leukemia virus but not after injection of vaccinia virus, despite the very similar kinetics and intensity of the immune response. Since retroviruses require activated target cells to induce efficient infection, these data suggest that the early polyclonal retrovirus-induced target cell activation might play an important role in the establishment of retroviral infections.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9311805      PMCID: PMC192072          DOI: 10.1128/JVI.71.10.7295-7299.1997

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus.

Authors:  D A Thorley-Lawson; L M Nadler; A K Bhan; R T Schooley
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

2.  Cytotoxic T cell clone-specific monoclonal antibodies used to select clonotypic antigen-specific cytotoxic T cells.

Authors:  H Acha-Orbea; R M Zinkernagel; H Hengartner
Journal:  Eur J Immunol       Date:  1985-01       Impact factor: 5.532

3.  Two monoclonal rat antibodies with specificity for the beta-chain variable region V beta 6 of the murine T-cell receptor.

Authors:  J Payne; B T Huber; N A Cannon; R Schneider; M W Schilham; H Acha-Orbea; H R MacDonald; H Hengartner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

4.  Characterization of a cell surface-expressed disulfide-linked dimer involved in murine T cell activation.

Authors:  W M Yokoyama; F Koning; P J Kehn; G M Pereira; G Stingl; J E Coligan; E M Shevach
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

5.  In vivo effects of a recombinant vaccinia virus expressing a mouse mammary tumor virus superantigen.

Authors:  C Krummenacher; H Diggelmann; H Acha-Orbea
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

Review 6.  How do T-cell receptors, MHC molecules and superantigens get together?

Authors:  D L Woodland; M A Blackman
Journal:  Immunol Today       Date:  1993-05

7.  Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome.

Authors:  R Nusse; H E Varmus
Journal:  Cell       Date:  1982-11       Impact factor: 41.582

8.  Positive selection determines T cell receptor V beta 14 gene usage by CD8+ T cells.

Authors:  N S Liao; J Maltzman; D H Raulet
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

9.  Integration of murine leukemia virus DNA depends on mitosis.

Authors:  T Roe; T C Reynolds; G Yu; P O Brown
Journal:  EMBO J       Date:  1993-05       Impact factor: 11.598

10.  Superantigen-reactive CD4+ T cells are required to stimulate B cells after infection with mouse mammary tumor virus.

Authors:  W Held; A N Shakhov; S Izui; G A Waanders; L Scarpellino; H R MacDonald; H Acha-Orbea
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

View more
  11 in total

1.  Interleukin-4 up-regulates mouse mammary tumor virus expression yet is not required for in vivo virus spread.

Authors:  J Czarneski; J Meyers; T Peng; V Abraham; R Mick; S R Ross
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.

Authors:  F Baribaud; S Wirth; I Maillard; S Valsesia; H Acha-Orbea; H Diggelmann
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Critical role of dendritic cells in mouse mammary tumor virus in vivo infection.

Authors:  Maria Cecilia Courreges; Dalia Burzyn; Irene Nepomnaschy; Isabel Piazzon; Susan R Ross
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

4.  Murine retroviruses activate B cells via interaction with toll-like receptor 4.

Authors:  John C Rassa; Jennifer L Meyers; Yuanming Zhang; Rama Kudaravalli; Susan R Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

5.  Role of dendritic cells in the immune response induced by mouse mammary tumor virus superantigen.

Authors:  F Baribaud; I Maillard; S Vacheron; T Brocker; H Diggelmann; H Acha-Orbea
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

6.  The VP7 outer capsid protein of rotavirus induces polyclonal B-cell activation.

Authors:  Sarah E Blutt; Sue E Crawford; Kelly L Warfield; Dorothy E Lewis; Mary K Estes; Margaret E Conner
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 7.  Mouse mammary tumor virus and the immune system.

Authors:  Jennifer Czarneski; John C Rassa; Susan R Ross
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

8.  Preactivation of B lymphocytes does not enhance mouse mammary tumor virus infection.

Authors:  D Finke; L Mortezavi; H Acha-Orbea
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

9.  T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin class switching.

Authors:  K M Toellner; S A Luther; D M Sze; R K Choy; D R Taylor; I C MacLennan; H Acha-Orbea
Journal:  J Exp Med       Date:  1998-04-20       Impact factor: 14.307

10.  ROS upregulation during the early phase of retroviral infection plays an important role in viral establishment in the host cell.

Authors:  Soo Jin Kim; Paul K Y Wong
Journal:  J Gen Virol       Date:  2013-07-24       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.